Better patient persistence with once-daily bupropion compared with twice-daily bupropion

American Journal of Therapeutics

Volumn 14, Issue 1, 2007, Pages 20-24

  Stang, Paul ^a,b,e   Young, Sam ^c   Hogue, Susan ^d  

^a WEST CHESTER UNIVERSITY   (United States)

^b Galt Associates Inc   (United States)

^c Catalina Health Resources   (United States)

^d GLAXOSMITHKLINE   (United States)

^e NONE   (United States)

Author keywords

Adherence; Antidepressant; Bupropion; Depression; Persistence

Indexed keywords

AMFEBUTAMONE;

ADULT; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DEMOGRAPHY; DEPRESSION; DOSAGE SCHEDULE COMPARISON; DRUG FORMULATION; FEMALE; HUMAN; KAPLAN MEIER METHOD; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; PATIENT ATTITUDE; PATIENT COMPLIANCE; PRESCRIPTION; PRIORITY JOURNAL;

ADULT; AGED; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; BUPROPION; DELAYED-ACTION PREPARATIONS; DEPRESSIVE DISORDER; FEMALE; HUMANS; INSURANCE CLAIM REVIEW; MALE; MIDDLE AGED; PATIENT COMPLIANCE;

EID: 33847162134     PISSN: 10752765     EISSN: None     Source Type: Journal    
DOI: 10.1097/MJT.0b013e31802b5954     Document Type: Article

References (22)

1. World Health Organization Global Burden of Disease (2000) Estimates. World Health Organization; 2006. Available at: www.who.int/healthinfo/bodgbd2000/en/index.html. Accessed January 28, 2006.
2. Callahan CM, Hui SL, Nienafer NA, et al. Longitudinal study of depression and health services use among elderly primary care patients. Am Geriatr Soc. 1994;42:833-838.
3. Simon GE, Von Korff M, Barlow W. Health care costs of primary care patients with recognized depression. Arch Gen Psychiatry. 1995;52:850-856.
4. Unützer J, Patrick DL, Simon G, et al. Depression symptoms and cost of health services in HMO patients aged 65 and older. A 4-year prospective study. JAMA. 1997;277:1618-1623.
5. Katon WJ. Clinical and health services relationship between major depression, depressive symptoms, and general medical illness. Biol Psychiatry. 2003;54:216-226.
6. Putnam K, McKibbin L. Managing workplace depression: an untapped opportunity for occupational health professionals. AAOHN J. 2004;52:122-129.
7. Goldberg RJ, Steury S. Depression in the workplace: costs and barriers to treatment. Psychiatry Serv. 2001;52:1639-1643.
8. Bruce ML, Wells KB, Miranda J, et al. Barriers to reducing burden of affective disorders. Ment Health Serv Res. 2002;4:187-197.
9. Kupfer DJ. Long-term treatment of depression. J Clin Psychiatry. 1991;52(Suppl 5):28-34.
10. Parikh SV, Lam RW; CANMAT Depression Workgroup. Clinical guidelines for the treatment of depressive disorders. I. Definitions, prevalence, and health burden. Can J Psychiatry. 2001;46(Suppl 1):13S-20S.
11. Masand PS. Tolerability and adherences issues in antidepressant therapy. Clin Ther. 2003;25:2289-2304.
12. Lin EH, Von Korff M, Katon W, et al. The role of the primary care physician in patients' adherence to antidepressant therapy. Med Care. 1995;33:67-74.
13. Maddox JC, Levi M, Thompson C. The compliance with antidepressants in general practice. J Psychopharmacol. 1994;8:48-53.
14. Bull SA, Hunkeler EM, Lee JY, et al. Discontinuing or switching selective serotonin reuptake inhibitors. Ann Pharmacother. 2002;36:578-584.
15. Kennedy S, McIntyre R, Fallu A, et al. Pharmacotherapy to sustain the fully remitted state. J Psychiatry Neurosci. 2002;27:269-280.
16. White TJ, Vanderplas A, Ory C, et al. Economic impact of patient adherence with antidepressant therapy within a managed care organization. Dis Manag Clin Outcomes. 2003;11:817-822.
17. Viale G. An economic analysis of physician prescribing of selective serotonin reuptake inhibitors. Hosp Pharm. 1998;33:847-850.
18. Eisen SA, Miller DK, Woodward RS, et al. The effect of prescribed daily dose frequency on patient medication compliance. Arch Intern Med. 1990;150:1881-1884.
19. Claxton AJ, Cramer J, Pierce C. A systematic review of the associations between dose regimens and medication compliance. Clin Ther. 2001;23:1296-1310.
20. Jefferson JW, Pradko JF, Muir KT. Bupropion for major depressive disorder: pharmacokinetic and formulation considerations. Clin Ther. 2005;27:1685-1695.
21. McLaughlin TP, Hogue SL, Stang P. Once-daily bupropion associated with improved patient adherence compared to twice-daily bupropion in treatment of depression. Am J Ther. In press.
22. Keene MS, Eaddy MT, Mauch RP, et al. Differences in compliance patterns across the selective serotonin reuptake inhibitors (SSRIs). Curr Med Res Opin. 2005;21:1651-1658.